BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37688396)

  • 1. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
    Zhang L; San Valentin EMD; John TM; Jenq RR; Do KA; Hanna EY; Peterson CB; Reyes-Gibby CC
    Cancer; 2024 Jan; 130(1):150-161. PubMed ID: 37688396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
    Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
    Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer.
    Vesty A; Gear K; Biswas K; Mackenzie BW; Taylor MW; Douglas RG
    Support Care Cancer; 2020 Jun; 28(6):2683-2691. PubMed ID: 31650293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of HSV-1/2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplastic treatment.
    Correia AV; Coêlho MR; de Oliveira Mendes Cahú GG; de Almeida Silva JL; da Mota Vasconcelos Brasil C; de Castro JF
    Support Care Cancer; 2015 Jul; 23(7):2105-11. PubMed ID: 25547479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study.
    Al-Qadami G; Bowen J; Van Sebille Y; Secombe K; Dorraki M; Verjans J; Wardill H; Le H
    Support Care Cancer; 2023 Jan; 31(1):98. PubMed ID: 36607434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of oral mucositis in advanced oral squamous cell carcinoma patients managed with prophylactic photobiomodulation therapy-insights for future protocol development.
    de Pauli Paglioni M; Faria KM; Palmier NR; Prado-Ribeiro AC; E Dias RB; da Graça Pinto H; Treister NS; Epstein JB; Migliorati CA; Santos-Silva AR; Brandão TB
    Lasers Med Sci; 2021 Mar; 36(2):429-436. PubMed ID: 32627112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
    Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
    Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
    Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.
    Allison RR; Ambrad AA; Arshoun Y; Carmel RJ; Ciuba DF; Feldman E; Finkelstein SE; Gandhavadi R; Heron DE; Lane SC; Longo JM; Meakin C; Papadopoulos D; Pruitt DE; Steinbrenner LM; Taylor MA; Wisbeck WM; Yuh GE; Nowotnik DP; Sonis ST
    Cancer; 2014 May; 120(9):1433-40. PubMed ID: 24877167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 nanoemulgel in prevention of radiation-induced oral mucositis and its associated effect on microbiome: a randomized clinical trial.
    Morsy BM; El Domiaty S; Meheissen MAM; Heikal LA; Meheissen MA; Aly NM
    BMC Oral Health; 2023 Aug; 23(1):612. PubMed ID: 37648997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.
    San Valentin EMD; Do KA; Yeung SJ; Reyes-Gibby CC
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer.
    Hayes RB; Ahn J; Fan X; Peters BA; Ma Y; Yang L; Agalliu I; Burk RD; Ganly I; Purdue MP; Freedman ND; Gapstur SM; Pei Z
    JAMA Oncol; 2018 Mar; 4(3):358-365. PubMed ID: 29327043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
    Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
    Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
    Alsubaie HM; Alsini AY; Alsubaie KM; Abu-Zaid A; Alzahrani FR; Sayed S; Pathak AK; Alqahtani KH
    Head Neck; 2021 Oct; 43(10):3199-3213. PubMed ID: 34240498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
    Shouval R; Eshel A; Dubovski B; Kuperman AA; Danylesko I; Fein JA; Fried S; Geva M; Kouniavski E; Neuman H; Armon-Omer A; Shahien R; Muller E; Noecker C; Borenstein E; Louzoun Y; Nagler A; Koren O
    Blood Adv; 2020 Jul; 4(13):2912-2917. PubMed ID: 32598476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
    Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
    JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
    Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
    Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.